Literature DB >> 28393116

Glutamine Metabolism in Cancer: Understanding the Heterogeneity.

Ahmad A Cluntun1, Michael J Lukey2, Richard A Cerione3, Jason W Locasale4.   

Abstract

Reliance on glutamine has long been considered a hallmark of cancer cell metabolism. However, some recent studies have challenged this notion in vivo, prompting a need for further clarifications on the role of glutamine metabolism in cancer. We find that there is ample evidence of an essential role for glutamine in tumors and that a variety of factors, including tissue type, the underlying cancer genetics, the tumor microenvironment and other variables such as diet and host physiology collectively influence the role of glutamine in cancer. Thus the requirements for glutamine in cancer are overall highly heterogeneous. In this review, we discuss the implications both for basic science and for targeting glutamine metabolism in cancer therapy.

Entities:  

Keywords:  Cancer Metabolism; Glutaminase; Glutamine Metabolism; TCA Cycle Anaplerosis

Mesh:

Substances:

Year:  2017        PMID: 28393116      PMCID: PMC5383348          DOI: 10.1016/j.trecan.2017.01.005

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  100 in total

1.  Nutrition needs of mammalian cells in tissue culture.

Authors:  H EAGLE
Journal:  Science       Date:  1955-09-16       Impact factor: 47.728

2.  An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

Authors:  Jemy A Gutierrez; Yuan-Xiang Pan; Lukasz Koroniak; Jun Hiratake; Michael S Kilberg; Nigel G J Richards
Journal:  Chem Biol       Date:  2006-12

3.  Bidirectional transport of amino acids regulates mTOR and autophagy.

Authors:  Paul Nicklin; Philip Bergman; Bailin Zhang; Ellen Triantafellow; Henry Wang; Beat Nyfeler; Haidi Yang; Marc Hild; Charles Kung; Christopher Wilson; Vic E Myer; Jeffrey P MacKeigan; Jeffrey A Porter; Y Karen Wang; Lewis C Cantley; Peter M Finan; Leon O Murphy
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

4.  Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.

Authors:  Sawako Suzuki; Tomoaki Tanaka; Masha V Poyurovsky; Hidekazu Nagano; Takafumi Mayama; Shuichi Ohkubo; Maria Lokshin; Hiroyuki Hosokawa; Toshinori Nakayama; Yutaka Suzuki; Sumio Sugano; Eiichi Sato; Toshitaka Nagao; Koutaro Yokote; Ichiro Tatsuno; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 5.  Metabolism and action of amino acid analog anti-cancer agents.

Authors:  G S Ahluwalia; J L Grem; Z Hao; D A Cooney
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

6.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

Authors:  Jian-Bin Wang; Jon W Erickson; Reina Fuji; Sekar Ramachandran; Ping Gao; Ramani Dinavahi; Kristin F Wilson; Andre L B Ambrosio; Sandra M G Dias; Chi V Dang; Richard A Cerione
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

7.  Pyruvate carboxylase is required for glutamine-independent growth of tumor cells.

Authors:  Tzuling Cheng; Jessica Sudderth; Chendong Yang; Andrew R Mullen; Eunsook S Jin; José M Matés; Ralph J DeBerardinis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 8.  Role of glutamine in human carbohydrate metabolism in kidney and other tissues.

Authors:  M Stumvoll; G Perriello; C Meyer; J Gerich
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

9.  c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Authors:  Ping Gao; Irina Tchernyshyov; Tsung-Cheng Chang; Yun-Sil Lee; Kayoko Kita; Takafumi Ochi; Karen I Zeller; Angelo M De Marzo; Jennifer E Van Eyk; Joshua T Mendell; Chi V Dang
Journal:  Nature       Date:  2009-02-15       Impact factor: 49.962

10.  Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).

Authors:  Mary M Robinson; Steven J McBryant; Takashi Tsukamoto; Camilo Rojas; Dana V Ferraris; Sean K Hamilton; Jeffrey C Hansen; Norman P Curthoys
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

View more
  172 in total

1.  Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.

Authors:  Nikita S Sharma; Vineet K Gupta; Vanessa T Garrido; Roey Hadad; Brittany C Durden; Kousik Kesh; Bhuwan Giri; Anthony Ferrantella; Vikas Dudeja; Ashok Saluja; Sulagna Banerjee
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 2.  Mitochondrial Metabolism as a Target for Cancer Therapy.

Authors:  Karthik Vasan; Marie Werner; Navdeep S Chandel
Journal:  Cell Metab       Date:  2020-07-14       Impact factor: 27.287

3.  SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis.

Authors:  Kai Su Greene; Michael J Lukey; Xueying Wang; Bryant Blank; Joseph E Druso; Miao-Chong J Lin; Clint A Stalnecker; Chengliang Zhang; Yashira Negrón Abril; Jon W Erickson; Kristin F Wilson; Hening Lin; Robert S Weiss; Richard A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 4.  Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Shashi Anand; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Lett       Date:  2020-01-07       Impact factor: 8.679

5.  Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements.

Authors:  Noam Yarom; Allan Hovan; Paolo Bossi; Anura Ariyawardana; Siri Beier Jensen; Margherita Gobbo; Hanan Saca-Hazboun; Abhishek Kandwal; Alessandra Majorana; Giulia Ottaviani; Monica Pentenero; Narmin Mohammed Nasr; Tanya Rouleau; Anna Skripnik Lucas; Nathaniel Simon Treister; Eyal Zur; Vinisha Ranna; Anusha Vaddi; Karis Kin Fong Cheng; Andrei Barasch; Rajesh V Lalla; Sharon Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.603

6.  Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.

Authors:  Deanna N Edwards; Verra M Ngwa; Ariel L Raybuck; Shan Wang; Yoonha Hwang; Laura C Kim; Sung Hoon Cho; Yeeun Paik; Qingfei Wang; Siyuan Zhang; H Charles Manning; Jeffrey C Rathmell; Rebecca S Cook; Mark R Boothby; Jin Chen
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

7.  Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.

Authors:  Larissa Menezes Dos Reis; Douglas Adamoski; Rodolpho Ornitz Oliveira Souza; Carolline Fernanda Rodrigues Ascenção; Krishina Ratna Sousa de Oliveira; Felipe Corrêa-da-Silva; Fábio Malta de Sá Patroni; Marília Meira Dias; Sílvio Roberto Consonni; Pedro Manoel Mendes de Moraes-Vieira; Ariel Mariano Silber; Sandra Martha Gomes Dias
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

8.  Glutamine deficiency promotes stemness and chemoresistance in tumor cells through DRP1-induced mitochondrial fragmentation.

Authors:  Parash Prasad; Sampurna Ghosh; Sib Sankar Roy
Journal:  Cell Mol Life Sci       Date:  2021-04-24       Impact factor: 9.261

9.  Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.

Authors:  Venkatrao Vantaku; Sri Ramya Donepudi; Danthasinghe Waduge Badrajee Piyarathna; Chandra Sekhar Amara; Chandrashekar R Ambati; Wei Tang; Vasanta Putluri; Darshan S Chandrashekar; Sooryanarayana Varambally; Martha K Terris; Kimberly Davies; Stefan Ambs; Roni Bollag; Andrea B Apolo; Arun Sreekumar; Nagireddy Putluri
Journal:  Cancer       Date:  2019-01-02       Impact factor: 6.860

Review 10.  Integration of Hippo-YAP Signaling with Metabolism.

Authors:  Consuelo Ibar; Kenneth D Irvine
Journal:  Dev Cell       Date:  2020-07-20       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.